Browsing by Author Tselepis, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 45 to 64 of 78 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
HDL as modulator of LpPLA(2)-mediated CVD riskTselepis, A.24-Nov-2015-
The hypertriglyceridaemic waist phenotype as a marker of the atherogenic lipoprotein profile in metabolic syndromeGazi, I.; Tsimihodimos, V.; Liamis, G.; Kostapanos, M.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Increase of HDL-associated platelet-activating-factor acetylhydrolase (PAF-AH) activity but not of paraoxonase (PON1) during haemodialysisLiberopoulos, E.; Papavasiliou, E.; Tzallas, C.; Katopodis, K.; Gouva, C.; Christidis, D.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015-
Increased activity of PAF-acetylhydrolase in low density lipoprotein subfractions induces enhanced lysophosphatidylcholine production in patients with heterozygous familial hypercholesterolemiaElisaf, M. S.; Karabina, A. S.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A.24-Nov-2015-
Increased PAF-acetylhydrolase activity in uremic patients: The influence of dialysis procedureMilionis, H.; Tselepis, A.; Karabina, S. A.; Vini, M.; Bairaktari, H.; Tziallas, C.; Elisaf, M. S.; Siamopoulos, K. C.24-Nov-2015-
Influence of Each Amino Acid Moiety within the 313-320 Cd41 Derived Sequence to Its Antiplatelet PropertiesStanica, R. M.; Rodis, F.; Tsoukatos, D.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
The influence of serum apolipoprotein e concentration and polymorphism on serum lipid parameters in hemodialysis patientsLiberopoulos, E.; Miltiadous, G.; Cariolou, M.; Katopodis, K.; Tselepis, A.; Siamopoulos, K. C.; Elisaf, M.24-Nov-2015-
Interaction of Platelet-Derived Microparticles with Plasma Lipoproteins. Effect on Platelet ActivationDimitriou, A.; Mitsios, J.; Tselepis, A.24-Nov-2015-
Is therapy with statins effective in patients with homozygous familial hypercholesterolaemiaElisaf, M. E.; Miltiadous, G.; Xenophontos, S.; Tsimihodimos, V.; Tselepis, A.; Cariolou, M.; Papathanasiou, A.; Goudevenos, I.24-Nov-2015-
LDL subfractions in patients with metabolic syndromeGazi, I.; Filippatos, T.; Bairaktari, E.; Kostara, C.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
The levels of autoantibodies against oxidized LDL in hypercholesterolemic patients are influenced by the LDL-associated PAF-acetylhydrolase activityLourida, E.; Tsouli, S.; Kiortsis, D.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Lipid Profile and Serum Levels of Markers of Inflammation in Patients with Acute BrucellosisApostolou, F.; Gazi, I.; Tselepis, A.; Elisaf, M.; Liberopoulos, E.24-Nov-2015-
Lipoprotein (a), apolipoprotein (a), phenotype and thyroid autoimmunity in patients with renal failureElisaf, M. S.; Katopodis, K.; Milionis, C.; Bairaktari, E.; Katsaraki, A.; Tselepis, A.; Karabina, S. A.; Tzallas, C.; Siamopoulos, K. C.24-Nov-2015-
Lipoprotein(a) and acute-phase response in patients with vestibular neuronitisMilionis, H.; Mittari, V.; Exarchakos, G.; Kalaitzides, R.; Rizos, E.; Kalogirou, M.; Skevas, A.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Lipoprotein(a) inhibits PAF-induced activation of human platelets in a manner independent of the endogenous PAF-acetylhydrolase activityTselepis, A.; Tsironis, L. D.; Mitsios, J. V.; Milionis, H. J.; Elisaf, M.24-Nov-2015-
Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particlesGazi, I.; Lourida, E.; Filippatos, T.; Tsimihodimos, V.; Saougos, V.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Long term treatment with atorvastatin does not affect the antiplatelet potency of clopidogrel in patients with acute coronary syndromesPapathanasiou, A.; Mitsios, J.; Rodis, F.; Tselepis, A.; Elisaf, M.; Goudevenos, J.24-Nov-2015-
Mapping the Fibrinogen Binding Sites of the Platelet Receptor Using Synthetic Peptides Derived from the Beta 3 SubunitStathopoulos, P.; Rodis, F.; Naydenova, E.; Tsoukatos, D.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
Oxidative stress is progressively enhanced with advancing stages of chronic kidney diseaseDounousi, E.; Papavasiliou, E.; Makedou, A.; Ioannou, K.; Katododis, K.; Tselepis, A.; Siamopoulos, K.; Tsakiris, D.24-Nov-2015-
Oxidative stress is progressively enhanced with advancing stages of CKDDounousi, E.; Papavasiliou, E.; Makedou, A.; Ioannou, K.; Katopodis, K. P.; Tselepis, A.; Siamopoulos, K. C.; Tsakiris, D.24-Nov-2015-